1049730-91-7

Basic information

• Product Name: 3-bromo-4-trifluoromethoxyanisole
• Synonyms: 3-bromo-4-trifluoromethoxyanisole;2-BroMo-4-Methoxy-1-(trifluoroMethoxy)benzene
• CAS NO: 1049730-91-7
• Molecular Formula: C₈H₆BrF₃O₂
• Molecular Weight: 271.0312496
• Mol File: 1049730-91-7.mol
• Article Data: 3

Chemical Properties

• Appearance: /
• Storage Temp.: Sealed in dry,Room Temperature
• CAS DataBase Reference: 3-bromo-4-trifluoromethoxyanisole(CAS DataBase Reference)
• NIST Chemistry Reference: 3-bromo-4-trifluoromethoxyanisole(1049730-91-7)
• EPA Substance Registry System: 3-bromo-4-trifluoromethoxyanisole(1049730-91-7)

Safety Data

• Hazardous Substances Data: 1049730-91-7(Hazardous Substances Data)

Usage

General Description

3-Bromo-4-trifluoromethoxyanisole is a chemical compound with the molecular formula C8H6BrF3O2. It is a white to off-white solid compound with a molecular weight of 263.03 g/mol. 3-Bromo-4-trifluoromethoxyanisole is commonly used in organic synthesis and pharmaceutical research as a building block for the preparation of various derivatives and pharmaceutical products. 3-Bromo-4-trifluoromethoxyanisole is known for its strong electron-withdrawing properties, which makes it useful in the creation of biologically active compounds. It is also used in the production of agrochemicals and in the field of material science for the development of new materials with specific properties. Additionally, it is important to handle this compound with care as it may pose health hazards if not handled properly.

Upstream product

• 886496-88-4 3-bromo-4-(trifluoromethoxy)phenol 
• 74-88-4 methyl iodide 

Downstream Products

• 1079402-25-7 5-methoxy-2-(trifluoromethoxy)-phenylboronic acid 

Relevant articles and documents

SUBSTITUTED CHROMEN-4-ONE FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION

The present invention provides novel compounds having the general formula: (I) wherein R1 to R10, Gi, G2 and m are as described herein, compositions including the impounds and methods of using the compounds for the treatment of hepatitis B.

PYRIDINE DERIVATIVES

The present invention relates to compounds of the formula (I): (I) and pharmaceutically acceptable salts and solvates thereof, to processes for the preparation of, intermediates used in the preparation of, and compositions containing such compounds and the uses of such compounds for the treatment of pain.